These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2650244)

  • 1. A micromethod for absorption of HLA class I antibodies.
    Vaidya S; Keesy J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):726-7. PubMed ID: 2650244
    [No Abstract]   [Full Text] [Related]  

  • 2. A microabsorption assay to determine acceptable HLA-A and B mismatches for highly immunized patients.
    van Eijck EL; van der Keur C; Gijbels Y; Bruning JW; van Rood JJ; Claas FH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):724-5. PubMed ID: 2650243
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic aspects of kidney transplantation].
    Frei D; Irlé C; Jeannet M
    Ther Umsch; 1986 Feb; 43(2):133-7. PubMed ID: 3515607
    [No Abstract]   [Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antileukocyte and antithrombocyte antibodies in correlation with the incidence of cytotoxic anti-HL-A antibodies in hematologic diseases of various etiology].
    Dinić B; Susaković N
    Bilt Hematol Transfuz; 1976; 4(3):11-6. PubMed ID: 1087555
    [No Abstract]   [Full Text] [Related]  

  • 8. A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness.
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Gabb BW
    Transplant Proc; 1979 Mar; 11(1):736-42. PubMed ID: 88102
    [No Abstract]   [Full Text] [Related]  

  • 9. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.
    Fuggle SV; Martin S
    Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossmatching on platelets by flow cytometry.
    Wang GX; Terashita GY; Terasaki PI
    Clin Transpl; 1988; ():381-5. PubMed ID: 3154488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

  • 12. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 13. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive autocrossmatch and slough of the ureteral mucosa: a case report.
    Halasz NA; Rearden CA; Parsons CL; Talner LB
    Transplant Proc; 1982 Dec; 14(4):743-7. PubMed ID: 6762734
    [No Abstract]   [Full Text] [Related]  

  • 16. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are maternal HLA antigens protective for antibody formation?
    Fluit L; Reekers P; Claas FH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):689-90. PubMed ID: 2650223
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiglobulin cytotoxic test. A study of factors responsible for non-specificity of reaction (author's transl)].
    Májský A
    Cas Lek Cesk; 1981 Jun; 120(25):764-9. PubMed ID: 6973395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.